Seeing Is Believing: Using Skype to Improve Diabetes Outcomes in Youth
Overview
Affiliations
Objective: The objective of this study was to compare the relative effectiveness of two modes of delivering Behavioral Family Systems Therapy for Diabetes (BFST-D) to improve adherence and glycemic control among adolescents with type 1 diabetes with suboptimal glycemic control (HbA(1c) ≥9.0% [≥74.9 mmol/mol]): face to face in clinic (Clinic) and Internet videoconferencing (Skype) conditions.
Research Design And Methods: Adolescents aged 12 to 18 years and at least one adult caregiver were randomized to receive BFST-D via the Clinic or Skype condition. Participants completed up to 10 therapy sessions within a 12-week period. Changes in youth- and parent-reported adherence and glycemic control were compared before and after the intervention and at follow-up assessment.
Results: Using an intent-to-treat analytic approach, no significant between-group differences were identified between the before, after, and follow-up assessments. Groups were collapsed to examine the overall effects of BFST-D on adherence and glycemic control. Results identified that statistically significant improvements in adherence and glycemic control occurred from before to after the intervention; improvements were maintained at 3-month follow-up.
Conclusions: Delivery of BFST-D via Internet-based videoconferencing is viable for addressing nonadherence and suboptimal glycemic control in adolescents with type 1 diabetes, potentially reducing important barriers to care for youth and families.
Rajan R, Dovbenyuk R, Kshatriya M, Yanikomeroglu S, Banfield L, Athale U Adolesc Health Med Ther. 2025; 15:109-117.
PMID: 40017672 PMC: 11865916. DOI: 10.2147/AHMT.S482859.
Erasmus P, Borrmann M, Becker J, Kuchinke L, Meinlschmidt G Interact J Med Res. 2025; 14:e46441.
PMID: 39993307 PMC: 11894358. DOI: 10.2196/46441.
Uses of Virtual Care in Primary Care: Scoping Review.
Agarwal P, Fletcher G, Ramamoorthi K, Yao X, Bhattacharyya O J Med Internet Res. 2025; 27:e55007.
PMID: 39951717 PMC: 11888022. DOI: 10.2196/55007.
Schurmann F, Westmattelmann D, Schewe G JMIR Form Res. 2025; 9:e54777.
PMID: 39869885 PMC: 11811669. DOI: 10.2196/54777.
James S, Saiyed M, James O, Gokalani R, Paterson M, Mehta K Diabetes Ther. 2025; 16(3):329-348.
PMID: 39799521 PMC: 11868000. DOI: 10.1007/s13300-024-01688-2.